2Drouet B, Le Loet X, Vittecoq O, et al. A study of longterm survival functional outcome and quality of life in patients with polymyositis or dermatomyositis [J]. Rev Rhum Engl Ed, 1996,63:321-330.
3Sigurgeirsson B,Lindelof B,Edhag O,et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study [J]. N Engl J Med, 1992,6: 363- 367.
4Henriksson KG, Sandstedt P. Polymyositis-treatment and prognosis:a study of 107 patients [J]. Acta Neurol Scand, 1982,65 : 280-300.
5Benbassat J,Gefel D, Larhoh K,et al. Prognostic factors in polymyositis/dermatomyositis. Acomputer-assisted analysis of ninety-two cases [J]. Arthritis Rheum, 1985,28: 249-255.
6Marie I, Hachulla E, Hatron P-Y, et al. Polymyositis and dermatomyositis:short term and long term outcome, and predictive factors of prognosis [J]. J Rheumatol, 2001,8 : 2230-2237.
7Bohan A, Peter JB, Bowman RL, et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis [ J ]. Medicine, 1977,56: 255-286.
8Metzger AL, Bohan A, Goldberg LS, et al. Polymyositis and dermatomyositis:combined methotrexate and corticosteroid therapy[J]. Ann Intern Med, 1974,81:182-189.
9Bunch TW. Prednisone and azathioprine for polymyositis: Long-term followup[J]. Arthritis Rheum, 198l ,24:45--48.
10Maugars YM, Berthelot JM,Abbas AA,et al. Long-term prognosis of 69 patients with dermatomyositis or polymyositis [J ]. Clin Exp Rheumatol, 1996,14: 2632- 2740.
